CompletedNCT03772951
The Efficacy of Computerized Cognitive Remediation Therapy for Chronic Schizophrenia
Medication studyAges 18–55China
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- Shanghai, ChinaSee all locations and recruitment
- Activities
- Medication and placebo comparator listed across study groups
- Compensation
- Payment and expense reimbursement have not been verified.
Study information
Study start dateStarted: January 10, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 154
- Sponsor
- Shanghai Mental Health Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- China
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT03772951
- Official title
Show the full official title
The Efficacy for Execution Function and Genetic Mechanism of Computerized Cognitive Remediation Therapy for Chronic Schizophrenia
Recruitment & locations
CompletedShanghai
Questions about this study
Who is behind this study?
The study sponsor is Shanghai Mental Health Center, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Clozapine.
Who was this study for?
Listed age limits: 18 years to 55 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meRelated studies
5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia
A 12-weeks Study to Evaluate the Dietary Fiber and Probiotics Treatment in Prevention and Intervention of Weight-gain and Cognitive Impairment of Schizophrenia or Bipolarity